TMC125HIV1083 - Swallowability of Uncoated 200 mg Etravirine Tablets in HIV-1 Infected Patients
NCT01090648
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
49
Enrollment
INDUSTRY
Sponsor class
Conditions
HIV-Infections
Interventions
DRUG:
etravirine
Sponsor
Tibotec Pharmaceuticals, Ireland